Aptus Pharma (APPL) Share Price near 52-week high: APPL at Rs 365

Aptus Pharma Share Price is in focus today as APPL trades at Rs 365, down 1.00% from the previous close of Rs 368.70, while remaining close to its 52-week high. Aptus Pharma Limited has a market capitalisation of Rs 632.32 crore, which keeps the move relevant for readers tracking Aptus Pharma Share Price Today, Aptus Pharma Stock News and Aptus Pharma Share News. According to latest Univest data, the stock is trading near a yearly high, but the figures shown here do not establish a company-specific catalyst. The session reading is useful because it brings together price, valuation and sector context in one place.

Aptus Pharma Share Price matters today because the current quote is being viewed alongside the stock’s prior session reference, its one-year high zone and its market capitalisation. The latest Univest figures confirm the price event, while the rest of the article separates what is directly observable from what cannot be inferred. For readers searching Aptus Pharma Share Price Today, Aptus Pharma Stock News and Aptus Pharma Share Price Update, the key point is simple: APPL is trading close to its 52-week high, and the valuation backdrop is materially richer than the broader industry benchmark.

Aptus Pharma Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 365
Previous Close	Rs 368.7
Today's Move	Rs -3.7 (-1%)
Open	Rs 365
High	Rs 365
Low	Rs 365
Market Capitalisation	Rs 632.32 crore

Aptus Pharma Limited (APPL) traded at Rs 365 versus the previous close of Rs 368.7, a fall of 1%. The stock opened at Rs 365, reached a high of Rs 365 and touched a low of Rs 365.

Aptus Pharma Share Price Today is Rs 365 versus the previous close of Rs 368.70, a move of Rs -3.70 or -1.00%. The stock opened at Rs 365 and also marked Rs 365 as the day’s high and low in the latest reading, which means the day’s range was flat at the time captured by Univest. That makes the current Aptus Pharma Share Price easy to anchor: the quote is near the 52-week high area, but still below the prior session reference.

For readers scanning Aptus Pharma Stock News, the exact price path matters more than narrative guesses. Aptus Pharma Share Price Today reflects a narrow intraday band at Rs 365, with no additional company-specific trigger established by the latest Univest data. The event remains useful for Stock Market Today and Share Market Today searches because it places APPL within a near-peak zone without turning that fact into a cause. Aptus Pharma Share Price therefore sits at a level that deserves monitoring as part of broader Market News and Stock Updates coverage.

Aptus Pharma Share Price also remains meaningful because the move is happening close to the 52-week high, which is the same as saying it is in the one-year high zone and near the yearly high. That is the factual event confirmed here. Aptus Pharma Share Price Today should be read with care: the current number is lower than the previous close, yet still positioned near the upper end of the stock’s recent range. For Univest readers, this is a clean price-action update rather than a catalyst story.

Aptus Pharma Limited (APPL) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 632.32 crore
P/E Ratio	136.87x
P/B Ratio	18.8x
ROE	30.48%
ROCE	30.01%
EPS	Rs 2.69
Book Value Per Share	Rs 19.61
Dividend Yield	0%

Aptus Pharma Limited (APPL) fundamental metrics show P/E 136.87x, P/B 18.8x, ROE 30.48%, ROCE 30.01%. These figures provide context only and are not a buy or sell signal.

Aptus Pharma Limited has a market capitalisation of Rs 632.32 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 136.87x, P/B at 18.8x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 30.48% and ROCE of 30.01%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 2.69, book value per share of Rs 19.61, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 13.27x, median ROE of 4.09%, median ROCE of 6.06%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Trading
Industry	Trading
Benchmark Scope	same industry
Company P/E Ratio	136.87x
Benchmark Median P/E	13.27x
Benchmark Average P/E	78.93x
Benchmark P/E Range	0x to 7,283.64x
Company P/B Ratio	18.8x
Benchmark Median P/B	1.33x
Company ROE	30.48%
Benchmark Median ROE	4.09%
Company ROCE	30.01%
Benchmark Median ROCE	6.06%
Company Market Capitalisation	Rs 632.32 crore
Benchmark Median Market Cap	Rs 53.15 crore

Aptus Pharma Limited (APPL) is classified under sector: Trading and industry: Trading.

Aptus Pharma Limited (APPL) has a P/E ratio of 136.87x, which is above the benchmark median of 13.27x, a difference of +931.42%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Aptus Pharma Limited (APPL) has a ROE of 30.48%, which is above the benchmark median of 4.09%, a difference of +645.23%. Aptus Pharma Limited (APPL) has a ROCE of 30.01%, which is above the benchmark median of 6.06%, a difference of +395.21%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
FABTECH TECHNOLOGIES LTD	FABTECH	635.42	13.02	1.5	12.94	15.51
Hardwyn India Ltd.	HARDWYN	629.09	52.23	1.51	2.9	4.3
The State Trading Corporation Of India Ltd.	STCINDIA	640.5	0.97	-0.13	0	0
Cellecor Gadgets Ltd.	CELLECOR	653.64	16.5	4.26	25.44	24.21
Uniphos Enterprises Ltd.	UNIENTER	603.17	29.39	0.26	0.85	0.85

Aptus Pharma Limited (APPL) has a P/E ratio of 136.87x compared with the displayed peer median of 16.5x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 30.48% compares with a peer median of 2.9% across the companies shown in the table. ROCE stood at 30.01% versus the displayed peer median of 4.3%, providing a capital-efficiency comparison. Aptus Pharma Limited (APPL) has a market capitalisation of Rs 632.32 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching Aptus Pharma

• Aptus Pharma Share Price is trading near its 52-week high and one-year high zone.
• The current Aptus Pharma Share Price Today reading is Rs 365 versus the previous close of Rs 368.70.
• Market capitalisation for Aptus Pharma Limited stands at Rs 632.32 crore.
• P/E of 136.87 and P/B of 18.8 place Aptus Pharma Share Price above the same-industry benchmark.
• ROE of 30.48% and ROCE of 30.01% are both well above the sector median.

About Aptus Pharma

Aptus Pharma Limited operates in the Trading sector and the Trading industry. In this context, Aptus Pharma Share Price is being tracked alongside benchmark data for 461 companies in the same industry. The available company profile here is focused on classification and market data rather than a long business description, so Aptus Pharma Share Price News is best understood through price action, valuation and peer comparison. For readers searching Aptus Pharma Share Price, the company sits within a broad trading universe where relative metrics matter.

Frequently Asked Questions

What is Aptus Pharma Share Price today?

Ans. Aptus Pharma Share Price is Rs 365 in the latest reading. It is down 1.00% from the previous close of Rs 368.70, and it remains near the 52-week high zone.

Why is Aptus Pharma Share Price in the news?

Ans. Aptus Pharma Share Price is in focus because the stock is trading close to its 52-week high while also carrying a market capitalisation of Rs 632.32 crore. The latest data confirms the price event.

Is Aptus Pharma Share Price near its one-year high?

Ans. Yes. Aptus Pharma Share Price is near its one-year high and yearly high zone. The current quote of Rs 365 sits close to that area, although the stock is still below the previous close of Rs 368.70.

What is the market capitalisation of Aptus Pharma?

Ans. Aptus Pharma Limited has a market capitalisation of Rs 632.32 crore. That places Aptus Pharma Share Price above the same-industry median market cap, though below the average market cap for the benchmark group.

How expensive is Aptus Pharma Share Price on valuation metrics?

Ans. Aptus Pharma Share Price trades at a P/E of 136.87 and a P/B of 18.8. Both numbers are far above the same-industry median, so the stock is valued richly on the displayed figures.

What do Aptus Pharma ROE and ROCE show?

Ans. Aptus Pharma reports ROE of 30.48% and ROCE of 30.01%. Both are well above the benchmark median and average in the same industry, which helps frame the company’s return profile.

What do EPS and book value mean for Aptus Pharma Share Price?

Ans. EPS is Rs 2.69 and book value is Rs 19.61 per share. EPS shows earnings per share, while book value shows accounting net worth per share. Both help place Aptus Pharma Share Price in context.

How does Aptus Pharma compare with peers?

Ans. Aptus Pharma Share Price sits near peers on market value but far above several of them on P/E and P/B. Its ROE and ROCE are also stronger than most of the listed comparables shown here.

Track Aptus Pharma Share Price on Univest

Use Aptus Pharma Limited (APPL) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Univest lets readers track Aptus Pharma Share Price Live, Aptus Pharma Share Price Today, benchmark ratios, sector comparison, peer comparisons and key company metrics in one place. Users can also review Aptus Pharma Fundamental Analysis, Aptus Pharma Stock Analysis and Aptus Pharma Latest News from the same stock page. For anyone following Aptus Pharma Share Price News, Univest keeps the quote, context and comparisons together.